Explore US Stem Cell analyst ratings and price targets (OTC:USRM) on Benzinga. Stay updated on expert opinions and forecasts for USRM stock.
There is no price target for US Stem Cell
There is no analyst for US Stem Cell
There is no last upgrade for US Stem Cell
There is no last downgrade for US Stem Cell.
There is no next analyst rating for US Stem Cell.
There is no next analyst rating for US Stem Cell.